179 related articles for article (PubMed ID: 37593736)
1. NK cells in peripheral blood carry trogocytosed tumor antigens from solid cancer cells.
Campos-Mora M; Jacot W; Garcin G; Depondt ML; Constantinides M; Alexia C; Villalba M
Front Immunol; 2023; 14():1199594. PubMed ID: 37593736
[TBL] [Abstract][Full Text] [Related]
2. Identification of Anti-tumor Cells Carrying Natural Killer (NK) Cell Antigens in Patients With Hematological Cancers.
Krzywinska E; Allende-Vega N; Cornillon A; Vo DN; Cayrefourcq L; Panabieres C; Vilches C; Déchanet-Merville J; Hicheri Y; Rossi JF; Cartron G; Villalba M
EBioMedicine; 2015 Oct; 2(10):1364-76. PubMed ID: 26629531
[TBL] [Abstract][Full Text] [Related]
3. Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients.
Suzuki E; Kataoka TR; Hirata M; Kawaguchi K; Nishie M; Haga H; Toi M
BMC Cancer; 2015 Feb; 15():39. PubMed ID: 25655677
[TBL] [Abstract][Full Text] [Related]
4. When killers become thieves: Trogocytosed PD-1 inhibits NK cells in cancer.
Hasim MS; Marotel M; Hodgins JJ; Vulpis E; Makinson OJ; Asif S; Shih HY; Scheer AK; MacMillan O; Alonso FG; Burke KP; Cook DP; Li R; Petrucci MT; Santoni A; Fallon PG; Sharpe AH; Sciumè G; Veillette A; Zingoni A; Gray DA; McCurdy A; Ardolino M
Sci Adv; 2022 Apr; 8(15):eabj3286. PubMed ID: 35417234
[TBL] [Abstract][Full Text] [Related]
5. NK Cells Acquire CCR5 and CXCR4 by Trogocytosis in People Living with HIV-1.
Vo DN; Leventoux N; Campos-Mora M; Gimenez S; Corbeau P; Villalba M
Vaccines (Basel); 2022 Apr; 10(5):. PubMed ID: 35632444
[TBL] [Abstract][Full Text] [Related]
6. Hijacking TYRO3 from Tumor Cells via Trogocytosis Enhances NK-cell Effector Functions and Proliferation.
Lu T; Ma R; Li Z; Mansour AG; Teng KY; Chen L; Zhang J; Barr T; Caligiuri MA; Yu J
Cancer Immunol Res; 2021 Oct; 9(10):1229-1241. PubMed ID: 34326137
[TBL] [Abstract][Full Text] [Related]
7. High Numbers of Circulating CD57
Muntasell A; Servitja S; Cabo M; Bermejo B; Pérez-Buira S; Rojo F; Costa-García M; Arpí O; Moraru M; Serrano L; Tusquets I; Martínez MT; Heredia G; Vera A; Martínez-García M; Soria L; Comerma L; Santana-Hernández S; Eroles P; Rovira A; Vilches C; Lluch A; Albanell J; López-Botet M
Cancer Immunol Res; 2019 Aug; 7(8):1280-1292. PubMed ID: 31189644
[TBL] [Abstract][Full Text] [Related]
8. CD45 Isoform Profile Identifies Natural Killer (NK) Subsets with Differential Activity.
Krzywinska E; Cornillon A; Allende-Vega N; Vo DN; Rene C; Lu ZY; Pasero C; Olive D; Fegueux N; Ceballos P; Hicheri Y; Sobecki M; Rossi JF; Cartron G; Villalba M
PLoS One; 2016; 11(4):e0150434. PubMed ID: 27100180
[TBL] [Abstract][Full Text] [Related]
9. Lymphocytes and Trogocytosis-Mediated Signaling.
Reed J; Reichelt M; Wetzel SA
Cells; 2021 Jun; 10(6):. PubMed ID: 34204661
[TBL] [Abstract][Full Text] [Related]
10. Peripheral blood NK cells from breast cancer patients are tumor-induced composite subsets.
Mamessier E; Pradel LC; Thibult ML; Drevet C; Zouine A; Jacquemier J; Houvenaeghel G; Bertucci F; Birnbaum D; Olive D
J Immunol; 2013 Mar; 190(5):2424-36. PubMed ID: 23359508
[TBL] [Abstract][Full Text] [Related]
11. Peripheral blood NK cells expressing HLA-G, IL-10 and TGF-β in healthy donors and breast cancer patients.
Ostapchuk YO; Cetin EA; Perfilyeva YV; Yilmaz A; Skiba YA; Chirkin AP; Omarbaeva NA; Talaeva SG; Belyaev NN; Deniz G
Cell Immunol; 2015; 298(1-2):37-46. PubMed ID: 26362675
[TBL] [Abstract][Full Text] [Related]
12. Enhanced cytotoxicity of natural killer cells following the acquisition of chimeric antigen receptors through trogocytosis.
Cho FN; Chang TH; Shu CW; Ko MC; Liao SK; Wu KH; Yu MS; Lin SJ; Hong YC; Chen CH; Hung CH; Chang YH
PLoS One; 2014; 9(10):e109352. PubMed ID: 25313995
[TBL] [Abstract][Full Text] [Related]
13. CD16
Frazao A; Messaoudene M; Nunez N; Dulphy N; Roussin F; Sedlik C; Zitvogel L; Piaggio E; Toubert A; Caignard A
Cancer Immunol Res; 2019 Feb; 7(2):208-218. PubMed ID: 30514793
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of IL-15 promotes tumor destruction via NK1.1+ cells in a spontaneous breast cancer model.
Gillgrass AE; Chew MV; Krneta T; Ashkar AA
BMC Cancer; 2015 Apr; 15():293. PubMed ID: 25879689
[TBL] [Abstract][Full Text] [Related]
15. Assessing
Reed J; Wetzel SA
Bio Protoc; 2020 May; 10(9):e3607. PubMed ID: 33659572
[TBL] [Abstract][Full Text] [Related]
16. Colon cancer cells acquire immune regulatory molecules from tumor-infiltrating lymphocytes by trogocytosis.
Shin JH; Jeong J; Maher SE; Lee HW; Lim J; Bothwell ALM
Proc Natl Acad Sci U S A; 2021 Nov; 118(48):. PubMed ID: 34819374
[TBL] [Abstract][Full Text] [Related]
17. Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity.
Mamessier E; Sylvain A; Thibult ML; Houvenaeghel G; Jacquemier J; Castellano R; Gonçalves A; André P; Romagné F; Thibault G; Viens P; Birnbaum D; Bertucci F; Moretta A; Olive D
J Clin Invest; 2011 Sep; 121(9):3609-22. PubMed ID: 21841316
[TBL] [Abstract][Full Text] [Related]
18. CAR-NK cell in cancer immunotherapy; A promising frontier.
Marofi F; Abdul-Rasheed OF; Rahman HS; Budi HS; Jalil AT; Yumashev AV; Hassanzadeh A; Yazdanifar M; Motavalli R; Chartrand MS; Ahmadi M; Cid-Arreguid A; Jarahian M
Cancer Sci; 2021 Sep; 112(9):3427-3436. PubMed ID: 34050690
[TBL] [Abstract][Full Text] [Related]
19. Engineering Receptor Expression on Natural Killer Cells Through Trogocytosis.
Somanchi A; Lee DA; Somanchi SS
Methods Mol Biol; 2016; 1441():253-65. PubMed ID: 27177672
[TBL] [Abstract][Full Text] [Related]
20. The breast tumor microenvironment alters the phenotype and function of natural killer cells.
Krneta T; Gillgrass A; Chew M; Ashkar AA
Cell Mol Immunol; 2016 Sep; 13(5):628-39. PubMed ID: 26277898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
